Skip to main content
. 2021 Mar 25;10(4):513. doi: 10.3390/antiox10040513

Figure 3.

Figure 3

TCS decreases cell proliferation of colorectal cancer (CRC) cells. (AD) Cell viability in CT26 (A), SW480 (B), and SW620 (C) on TCS treatment. Cells were seeded in 96-well plates and treated with TCS (1–100 μM). After incubation, cell viability was determined by WST-1 assay. Data are expressed as the mean ± SD of three independent experiments. * p < 0.05. (D) Morphology of TCS-treated CT26 cells for 48 h.